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ABSTRACT Human papillomavirus (HPV) infection is the world’s most common
sexually transmitted infection and is responsible for most cases of cervical can-
cer. Previous studies of global gene expression changes induced by HPV infec-
tion have focused on the cancerous stages of infection, and therefore, not much
is known about global gene expression changes at early preneoplastic stages of
infection. We show for the first time the global gene expression changes during
early-stage HPV16 infection in cervical tissue using 3-dimensional organotypic
raft cultures, which produce high levels of progeny virions. cDNA microarray
analysis showed that a total of 594 genes were upregulated and 651 genes were
downregulated at least 1.5-fold with HPV16 infection. Gene ontology analysis
showed that biological processes including cell cycle progression and DNA me-
tabolism were upregulated, while skin development, immune response, and cell
death were downregulated with HPV16 infection in cervical keratinocytes. Indi-
vidual genes were selected for validation at the transcriptional and translational
levels, including UBC, which was central to the protein association network of
immune response genes, and top downregulated genes RPTN, SERPINB4, KRT23,
and KLK8. In particular, KLK8 and SERPINB4 were shown to be upregulated in
cancer, which contrasts with the gene regulation during the productive replica-
tion stage. Organotypic raft cultures, which allow full progression of the HPV life
cycle, allowed us to identify novel gene modulations and potential therapeutic
targets of early-stage HPV infection in cervical tissue. Additionally, our results
suggest that early-stage productive infection and cancerous stages of infection
are distinct disease states expressing different host transcriptomes.
IMPORTANCE Persistent HPV infection is responsible for most cases of cervical can-
cer. The transition from precancerous to cancerous stages of HPV infection is
marked by a significant reduction in virus production. Most global gene expression
studies of HPV infection have focused on the cancerous stages. Therefore, little is
known about global gene expression changes at precancerous stages. For the first
time, we measured global gene expression changes at the precancerous stages of
HPV16 infection in human cervical tissue producing high levels of virus. We identi-
fied a group of genes that are typically overexpressed in cancerous stages to be sig-
nificantly downregulated at the precancerous stage. Moreover, we identified signifi-
cantly modulated genes that have not yet been studied in the context of HPV
infection. Studying the role of these genes in HPV infection will help us understand
what drives the transition from precancerous to cancerous stages and may lead to
the development of new therapeutic targets.
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Human papillomavirus (HPV) infection is the world’s most common sexually trans-mitted infection, with approximately 291 million women worldwide being infected
with the virus at any given point in time (1). While low-risk HPV types cause benign
warts in the anogenital area, persistent infection with high-risk HPV types can give rise
to various cancers of epithelial origin. In particular, HPV is responsible for most cases of
cervical cancer, which is the third most common cancer in women worldwide and the
most common cancer in women in developing countries (2). For this reason, the
mechanism of HPV infection and HPV-mediated oncogenesis has been extensively
studied. Early viral proteins E6 and E7 have been identified to be oncoproteins that play
a critical role in tumorigenesis and tumor maintenance by inhibiting the tumor sup-
pressor genes TP53 and RB1, respectively (3–10).
HPV initially infects dividing cells of the basal layer of the epidermis via microabra-
sions. Most infections are naturally resolved, but in some cases, the virus establishes a
persistent infection, which may subsequently progress to precancerous lesions that are
histologically graded as cervical intraepithelial neoplasia (CIN) grades I to III. When left
untreated, these neoplastic lesions may ultimately develop into carcinoma in situ and
invasive cancer. In persistently infected cervical tissue with normal or low-grade
dysplasia, the HPV genome is maintained episomally and infectious viral particles are
produced. In contrast, progression to severe dysplasia and invasive cancer is marked by
integration of the viral genome into the host genome, which typically results in
disruption of the E2 gene, the subsequent upregulation of oncogenes E6 and E7, and
abrogation of virion production (11, 12).
In the past, many studies have looked into changes in the whole-genome expression
profiles of precancerous and cancerous lesions in order to better understand the
progression of persistent HPV infection to cervical cancer. However, most of these
studies focused on neoplastic lesions and cancerous lesions (13–21) because it is
difficult to acquire clinical samples at earlier stages of infection when patients are
largely asymptomatic. Therefore, there is a gap in knowledge of global gene expression
in the earlier preneoplastic stages of the disease, when HPV establishes productive
infection in the host. In two recent studies, human keratinocytes persistently infected
with HPV16 were used to measure global gene expression changes (22, 23), but they
used keratinocytes derived from foreskin, which may not be appropriate for modeling
infection in cervical tissue since HPV may have tissue-specific effects (24). Furthermore,
these studies used monolayer cell cultures that do not produce virions by disallowing
the virus to progress through its differentiation-dependent replication life cycle (25, 26).
In other studies, overexpression tools were used to examine the effect of specific HPV
oncoproteins on global gene expression (27, 28). Since these studies examined the
effect of only individual viral proteins, they did not account for the full picture of HPV
infection in the natural environment.
In this study, we used oligonucleotide microarrays to measure global gene expres-
sion changes in early-passage HPV16-infected human cervical keratinocytes (16HCK).
Organotypic raft cultures were used in order to allow the virus to go through its full life
cycle. A total of 594 and 651 genes were at least 1.5-fold upregulated and downregu-
lated, respectively. Gene ontology analysis of upregulated genes identified biological
processes that were significantly represented, including the cell cycle process and DNA
metabolism. In contrast, biological processes that were significantly represented by
downregulated genes included epidermis development, extracellular matrix disassem-
bly, and regulation of NF-B signaling.
(This article was submitted to an online preprint archive [29].)
RESULTS
Microarray analysis of HPV16 infection in cervical tissue. Global gene expression
changes in cervical tissue infected with HPV16 at a preneoplastic state were measured
by conducting cDNA microarray analysis (GEO accession no. GSE109039) on 10-day
organotypic raft tissue from early-passage human cervical keratinocytes (HCK)
persistently infected with HPV16 (16HCK). In order to create 16HCK cell lines, human
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cervical tissue from biopsy specimens were acquired, processed, and cultured with
keratinocyte-selective medium to grow primary HCKs. The HCKs were then electropo-
rated with the HPV16 genome to establish persistent infection and immortalization. We
used organotypic raft cultures, as previously described, which allow us to observe the
full HPV life cycle in 3-dimensional (3D) tissue at a precancerous stage of infection when
HPV particles are maximally produced. The organotypic raft tissue was harvested for
microarray analysis at 10 days of culture, when particle production is most active (30),
and 20 days of culture, when particle maturation is at its maximum (31), to measure the
viral titer showing that virus particles are produced at high levels (Table 1). By infecting
each cell line with the same virus and subjecting the raft cultures to the same condition,
we were able to minimize variables and observe the specific effect of HPV infection on
cervical tissue.
The experiment was conducted in six individually grown raft tissue specimens
representing three donor 16HCK cell lines, and raft tissue from uninfected HCKs served
as a control. Out of the 34,575 genes that were analyzed with the cDNA microarray, a
total of 1,245 genes were modified at least 1.5-fold (P  0.05) and 533 genes were
modified at least 2-fold (P  0.05) with HPV16 infection compared to their expression
in the uninfected control (see Table S1 in the supplemental material). The average of
the pairwise Pearson correlation of the primary HCK samples was 0.885, and that of the
16HCK samples was 0.941. Of those genes that were significantly modulated at least
1.5-fold, 594 genes were upregulated and 651 genes were downregulated. Tables 2 and 3
show the 50 most upregulated and the 50 most downregulated genes in the microarray
analysis, respectively. Among the top 50 upregulated genes were those associated with
the cell cycle (CDKN2A, CDC7, NASP, MDC1, NFIX, FOXQ1). In contrast, the 50 most
downregulated genes span from those involved in differentiation (RPTN, LCE1D, LCE3C,
LCE1E, S100A7), extracellular matrix (ECM) modulation (KLK6, KLK8, KLK10, KLK13, MMP9,
and MMP10), and immune regulation (LCN2, SPNS2, FAM3D, IL1RN, PSG4, IL1F7) to the
antimicrobial response (RNASE7, PRSS3, PRSS2). This suggests that HPV infection drives
the cell cycle and disrupts epidermal differentiation and ECM homeostasis while
evading the immune and antimicrobial responses by downregulating them.
While most previous global gene expression studies have focused on neoplastic and
cancerous stages of HPV infection (13–21), two previous studies have modeled pre-
neoplastic, early-stage HPV infection, similar to our study (22, 23). However, most of the
modulated genes in the two studies did not overlap our results. One of these studies
reported that 135 genes were modulated with HPV infection, but only 38 (28.1%) of
these were modulated in the same direction and 4 of them were modulated in the
opposite direction in our microarray analysis (22). In the other study, a total of 966
genes were reported to be modulated with HPV infection, but only 15 (1.6%) of these
were modulated in the same direction in our microarray analysis (23). The two major
differences between our study and the two previous studies are that we used cervical
keratinocytes instead of foreskin keratinocytes and that we used organotypic raft
cultures instead of monolayer cultures, which do not allow HPV to complete its life
cycle. The use of keratinocytes derived from cervical tissue and organotypic raft cultures
that allow the virus to complete its life cycle in 3D tissue enables us to capture the
whole picture of an early-stage HPV infection in the cervix.
While the fold change in expression of the 50 most upregulated genes ranged from
12.1 to 2.5, that of the 50 most downregulated genes ranged from 57.5 to 6, indicating
TABLE 1 Viral titers of organotypic rafts
Raft identification No. of viral particles/raft
16HCK-1, replicate 1 9.38  107
16HCK-1, replicate 2 1.18  107
16HCK-2, replicate 1 5.25  108
16HCK-2, replicate 2 6.5  109
16HCK-3, replicate 1 5.81  107
16HCK-3, replicate 2 1.6  109
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that a greater degree of gene modulation occurred in the downregulated genes than
in the upregulated genes. Similarly, when the cutoff for inclusion was increased to at
least a 5-fold modulation, only 6 genes were upregulated; in contrast, 72 genes were
downregulated, as shown in Fig. 1. This suggests that HPV16 disrupts the host’s
physiology mostly by dampening many of the normal processes that may interfere with
the virus’s survival and replication.
Gene ontology analysis. In order to identify the biological pathways that are
significantly affected with HPV16 infection, we conducted gene ontology (GO) analysis
using the online tool GOrilla (Tables S2 and S3) (32). The GO analysis result was then
TABLE 2 Top 50 upregulated genes with productive HPV16 infection
Gene Description or functiona
Fold change
in expression
MT1G Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are
transcriptionally regulated by both heavy metals and glucocorticoids
12.032
MT1H Mineral absorption/metabolism 7.679
TGFBR3 Binds to TGF-; could be involved in capturing and retaining TGF- for presentation to the signaling receptors 7.295
KLHL35 Kelch-like family member; Kelch-repeat -propellers are generally involved in protein-protein interactions 5.814
DLK2 Calcium ion binding and protein dimerization activity 5.057
FBLN1 Cell adhesion/migration/ECM architecture organization 5.056
ASS1 Arginine biosynthetic pathway 4.446
GPER G protein-coupled estrogen receptor; cAMP signaling, calcium mobilization 4.446
TDRD9 Probable ATP binding RNA helicase 4.393
TWIST1 Transcription factor, role in cell lineage determination and differentiation 4.208
FANCE Member of the Fanconi anemia complementation group E 4.183
JAM3 Cell-to-cell adhesion in epithelial and endothelial cells 4.169
CDKN2A Cell cycle regulation 4.122
TSPAN4 A cell surface protein that mediates cell development, activation, growth, and motility 3.733
LTBP4 Involved in assembly, targeting, and activation of TGFB1 3.718
ERAP2 Aminopeptidase involved in peptide trimming, MHC class I presentation 3.551
LOC341230 Similar to argininosuccinate synthetase 3.454
MXRA5 Matrix remodeling-associated proteins 3.281
RPS23 Component of the 40S ribosomal subunit 3.23
C14orf132 Putative uncharacterized protein 3.165
CRIP2 Putative transcription factor with two LIM zinc binding domains 3.148
ANGPTL2 Member of the vascular endothelial growth factor family 3.061
GOLPH4 Involved in endosome-to-Golgi apparatus protein trafficking 3.058
DPYSL2 Cytoskeletal remodeling, endocytosis 3.013
CDC7 Checkpoint control kinase critical for G1/S transition 2.981
FAM134B ER-anchored autophagy receptor 2.947
NASP Histone binding protein with a role in cell division, cell cycle progression, and proliferation 2.885
HEG1 Calcium ion binding receptor component; may act through stabilization of endothelial cell junctions 2.866
ZCWPW1 Zinc finger domain-containing protein 2.8
MTE Metallothioneins have a high content of cysteine residues that bind various heavy metals 2.786
MDC1 Required for checkpoint-mediated cell cycle arrest in response to DNA damage 2.783
CDH13 Calcium-dependent cell adhesion proteins 2.775
OLFML2A Extracellular matrix binding protein 2.762
LOC392871 Undetermined gene ortholog 2.728
CYBRD1 Ferric chelate reductase 2.726
RASIP1 Ras-interacting protein required for the formation of vascular structures 2.721
LOC729137 Undetermined gene ortholog 2.7
GPNMB Type 1 transmembrane glycoprotein 2.693
MOBKL2B May regulate the activity of kinases 2.672
LOC388494 Undetermined gene ortholog 2.645
C10orf54 Putative uncharacterized protein 2.644
E2F2 E2F family of transcription factors 2.572
LFNG Transferase enzyme 2.571
LOC100133866 Undetermined gene ortholog 2.568
NFIX DNA binding protein, capable of activating transcription and replication 2.56
P4HTM Prolyl hydroxylases 2.553
RELL1 Receptor expressed in lymphoid tissue-like 1 2.551
FOXQ1 FOX genes are involved in gene development, cell proliferation, and tissue-specific gene expression 2.53
TJAP1 Tight junction-associated protein 2.527
HOXA11AS Noncoding RNA gene 2.525
FN3KRP Phosphorylates psicosamines and ribulosamines 2.514
aTGF-, transforming growth factor ; MHC, major histocompatibility complex; ER, endoplasmic reticulum.
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summarized using the REVIGO web server to combine similar GO terms for simplified
visualization (33). A total of 144 GO terms that were significantly represented in
upregulated genes were summarized to 82 GO terms using REVIGO (Table S4), and 77
GO terms that were significantly represented in downregulated genes were summa-
rized to 52 GO terms using REVIGO (Table S5).
Among the genes that were upregulated with HPV16 infection, many of the
represented GO terms are associated with cell cycle progression (the cell cycle process,
cell division, cell cycle phase transition, regulation of mitotic cell cycle, and the cell
TABLE 3 Top 50 downregulated genes with productive HPV16 infection
Gene Description or function
Fold change
in expression
RPTN Involved in cornified cell envelope formation; multifunctional epidermal matrix protein; reversibly binds calcium 57.487
SERPINB4 May act as a protease inhibitor to modulate the host immune response against tumor cells 48.016
TCN1 Binds vitamin B12 and protects it from the acidic environment of the stomach 34.735
CST6 Active cysteine protease inhibitors; loss of function is associated with progression of a primary tumor to a
metastatic phenotype
27.758
KLK8 Serine proteases with diverse physiological functions 25.804
CEACAM6 GPIa-anchored glycoprotein; plays a role in cell adhesion 24.469
KLK6 Serine proteases regulated by steroids 22.088
KLK13 Expression regulated by steroid hormones and an important marker for breast cancer 21.464
RNASE7 Pancreatic ribosomal protein; broad-spectrum antimicrobial activity against bacteria and fungi 20.029
PRSS3 Digestive protease specialized for the degradation of trypsin inhibitors; in the ileum, may be involved in
processing of defensin, including DEFA5
19.968
LCE1D Precursors of the cornified layers of the stratum corneum 17.868
MMP9 Zinc-dependent endopeptidases and major proteases involved in the degradation of the ECM 17.142
FLJ22662 Weak phospholipase activity; may act as an amidase or peptidase 14.394
TMEM45B Transmembrane protein 45B 13.469
DMKN Expressed in differentiated layers of the skin; upregulated in inflammatory disease 13.186
C6orf15 Uncharacterized protein-coding gene 12.641
TMEM45A Paralog of TMEM45B 12.629
PNLIPRP3 Triglyceride lipase activity 11.232
KRT23 Intermediate filament protein 11.074
ANXA9 Calcium-dependent phospholipid binding protein; binds ECM proteins 10.728
LCE3C Precursors of the cornified layers of the stratum corneum 10.044
S100A7 Calcium binding proteins involved in cell cycle progression and cellular differentiation 9.88
EPS8L1 Substrate for the epidermal growth factor receptor 9.659
RORA Member of NR1 family of nuclear hormone receptors 9.136
LCN2 Iron-trafficking protein involved in apoptosis, innate immunity, and renal development 9.134
LCE1E Precursors of the cornified layers of the stratum corneum 9.067
SPNS2 Sphingolipid transporter with a critical function in cardiovascular, immunological, and neuronal development 8.787
FAM3D Related to cytokine activity 8.734
KLK7 Member of the kallikrein family of serine proteases 8.61
HMOX1 Heme oxygenase, an essential enzyme in heme catabolism 8.548
RNF39 Role in early phase of synaptic plasticity 8.5
SH3BGRL2 Protein disulfide oxidoreductase activity 8.478
C1orf68 Uncharacterized protein-coding gene 8.417
POF1B Key role in organization of the epithelial monolayers by regulating the actin cytoskeleton 8.233
ATP6V1C2 Subunit of the peripheral V1 complex of the vacuolar ATPase 8.232
MMP10 Zinc-dependent endopeptidases and major proteases involved in the degradation of the ECM 7.953
LOC730833 Undetermined gene ortholog 7.935
CAPNS2 Calcium-regulated thiol protease; role in tissue remodeling and signal transduction 7.64
KLK10 Member of the kallikrein family of serine proteases 7.553
IL1RN Inhibits the activity of interleukin-1 7.499
ABCG1 Intracellular lipid transport 7.408
THEM5 Role in mitochondrial fatty acid metabolism 7.287
CYP2J2 Role in arachidonic acid metabolism 7.259
PRSS2 Serine protease involved in defensin processing 7.239
LOC645869 Undetermined gene ortholog 6.803
PSG4 May play a role in regulation of innate immune system 6.559
FAM63A Role in protein turnover, deubiquitinase activity 6.52
MAP2 Stabilizing/stiffening of microtubules 6.474
SLC5A1 Na/glucose cotransporter 6.468
IL1F7 Interleukin-1-related gene 6.392
EPB41L3 Tumor suppressor that inhibits cell proliferation and promotes apoptosis 6.356
aGPI, glycosylphosphatidylinositol.
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cycle) and DNA metabolism (DNA metabolic process, DNA repair, cellular response to
DNA damage stimulus), as shown in Fig. 2A. This suggests that persistent infection with
HPV16 drives cellular proliferation in cervical tissue, as expected, due to the presence
of viral oncogenes E6/E7, a finding consistent with the results of previous gene
expression studies (16, 19, 27, 34). It is known that HPV oncoproteins E6 and E7 inhibit
tumor suppressor genes TP53 and RB1, respectively, and that this is the main mecha-
nism through which the virus promotes proliferation and tumorigenesis. “Translesion
synthesis,” “neuron projection regeneration,” and “retina morphogenesis in camera-
type eye” were among the upregulated DNA metabolism GO terms which have not yet
been reported by previous global gene expression studies of HPV16 infection (Table
S2). Translesion synthesis is a cellular DNA damage tolerance process of recovering
from stalled replication forks by allowing DNA replication to bypass certain lesions (35,
36). Eight genes of the translesion synthesis GO category were upregulated in our
analysis, including POLE2, UBA7, MAD2L2, and RPA2, which have not yet been reported
in previous global gene expression studies of HPV infection. So far, not much is known
about the exact role of translesion synthesis in HPV infection. One previous study
speculated that HPV oncoprotein E6 may have inhibitory effects on translesion syn-
thesis (37), while another study reported that p80, a cellular cofactor of HPV31
replication, may downregulate translesion synthesis (35). Our study shows for the first
time that translesion synthesis is upregulated in a productive raft culture model of
HPV16, suggesting that this process may facilitate viral replication and production.
Among the genes that were downregulated with HPV16 infection, the GO terms that
were significantly represented are associated with skin development (epidermis devel-
opment, keratinocyte differentiation), immune response (positive regulation of IB
kinase [IKK]/NF-B signaling, antimicrobial humoral response), and cell death (cell
FIG 1 Heat map of genes whose expression was significantly modified. Six raft experiments, each with 16HCK and primary HCK cell lines representing three
donors each, were set up. The tissues were harvested at 10 days of culture for RNA extraction and microarray analysis. The heat map shows genes whose
expression was significantly modulated (P  0.05) at least 5-fold with HPV16 infection.
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death, positive regulation of Jun N-terminal protein kinase [JNK] cascade), as shown in
Fig. 2B. The downregulation of genes associated with skin development has also been
observed in previous studies of HPV-positive tumors (13, 17, 38). Similarly, the down-
regulation of genes under GO terms associated with the immune response and cell
death has been shown in previous studies of HPV-positive tumors and E6 transgenic
mice (15, 18, 22, 23, 28, 39). Overall, these results suggest that HPV16 perturbs normal
epidermal development while having a hyperproliferative and immunosuppressive
effect on cervical tissue. The GO terms for downregulated genes that have not yet been
reported in previous global gene profiling studies of HPV infection included “positive
regulation of cell migration” and “regulation of platelet-derived growth factor produc-
tion” (Table S5). In contrast to our results, previous studies of global gene expression at
cancerous stages of HPV infection have shown the upregulation of genes involved in
cell migration, which is an indicator of invasive or metastatic cancer (15, 20, 40).
Specifically, one study showed that MMP9, a well-established metastatic gene, is
upregulated in cervical carcinoma cell lines and tissue samples, whereas our microarray
analysis showed that this gene is downregulated 17.1-fold (40). Moreover, LCN2, which
is overexpressed in various cancers and prevents the degradation of MMP9, was
downregulated 9.1-fold in our microarray analysis (41–48). These opposing trends in
modulation of cell migration genes highlight the fact that our study investigated early
productive stages of HPV infection, whereas the other studies focused on the cancerous
stages of infection, when viral production is significantly decreased. We speculate that
cell migration genes interfere with efficient viral replication and assembly and, there-
fore, are suppressed during the productive stages of infection, whereas these genes are
upregulated to facilitate tumor development and metastasis once the infection enters
the cancerous stages.
FIG 2 Enriched GO terms with the lowest P values. The online tool GOrilla was used to perform the initial GO analysis of our microarray
data, and the REVIGO web server was used to summarize the enriched GO gene sets from the upregulated (A) and downregulated
(B) lists of genes. The entire list of GO terms can be found in Tables S4 and S5 in the supplemental material. met. proc., metabolic
process; PDGF, platelet-derived growth factor; VEGF, vascular endothelial growth factor; pos. reg., positive regulation.
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Upregulation of the cell cycle and DNA metabolism. While GO analysis revealed
biological processes that are significantly affected by persistent infection of HPV16, it
does not provide information on interactions among the genes. Therefore, we further
examined the interaction among individual proteins based on published data using the
online tool STRING (49, 50). STRING protein-protein interaction network analysis allows
us to identify signaling pathways, interactions among signaling pathways, and central
proteins that have maximum interactions with other proteins within a category. A
protein association network was created for each of the five aforementioned categories
of biological processes that were broadly represented in the GO analysis: the cell cycle,
DNA metabolism, skin development, immune response, and cell death.
From the upregulated genes, a protein association network was created with genes
from 32 GO terms related to the cell cycle (Fig. 3A; Table S6). Genes that are not known
to be associated with any other gene in this group were excluded from Fig. 3 for
simplified visualization. The protein association analysis revealed 15 genes that are
central to the network, as highlighted in red in Fig. 3A. These genes include nucleo-
porins (NUP43, NUP85, NUP107), centromere proteins (CENPE, CENPF, CENPP), and
kinetochore-associated proteins (KNTC1, SKA2). This suggests that HPV infection drives
the cell cycle and increases the expression of structural proteins involved in the cell
FIG 3 Protein association networks. The online tool STRING was used to create protein functional association networks of upregulated (A and B) and
downregulated (C to E) genes with a 1.5-fold modulation of expression (P  0.05). (A) Genes from GO categories related to cell cycle regulation were
combined to create the network. (B) Genes from GO categories related to DNA metabolism were combined to create the network. (C) Genes from GO categories
related to skin development and differentiation were combined to create the network. (D) Genes from GO categories related to inflammation and the immune
response were combined to create the network. (E) Genes from GO categories related to apoptosis and cell death were combined to create the network. Thicker
and darker lines represent greater confidence in the protein interaction on the basis of the supporting data. Genes that had no connection to any other gene
within the network were excluded from the diagram.
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cycle and cell division. Among these genes, NUP43, NUP85, NUP107, CENPP, and SKA2
have not yet been reported to be associated with HPV infection by previous gene
expression studies.
Similarly, a protein association network was created with genes from 42 GO terms
related to DNA metabolism (Fig. 3B; Table S7). The genes in this network included
minichromosome maintenance (MCM) complex components (MCM3, MCM6, MCM7),
replication factors (RFC2, RFC3, RFC5), and DNA polymerase subunits (POLA1, POLE,
POLE2, POLD1). Among these genes, POLA1, POLE, and POLE2 have not yet been
reported to be associated with HPV infection by previous gene expression studies.
Previous studies have shown that overexpression of MCM genes is correlated with
cervical carcinogenesis, and specifically, MCM7 has been shown to interact with the
HPV18 E6 oncoprotein (51, 52). These results are consistent with the upregulation of
cell cycle genes since cell division requires DNA replication and proteins associated
with DNA metabolism. Additionally, our result suggests that the upregulation of MCM
genes is initiated at early stages of HPV infection and sustained throughout carcino-
genesis.
Downregulation of skin development, immune response, and cell death. Within
the downregulated gene sets, we combined genes from 7 GO terms in the protein
association analysis for skin development, which gave 4 small networks (Fig. 3C; Table
S8), including a network of late cornified envelope (LCE) genes (LCE1D, LCE1E, LCE1F,
LCE3C, LCE4A, LCE5A) and a network of laminins (LAMA3, LAMB3, LAMC2). All eight genes
in the network of LCEs were included in the GO term “epithelial cell differentiation,”
while the three laminin genes were included in the GO term “epidermis development.”
The LCE genes encode stratum corneum proteins of the epidermis and are all located
in the same region of chromosome 1 (1q21.3), suggesting that epigenetic modifications
might suppress the expression of this region as a whole. Our study shows for the first
time the downregulation of a network of LCE genes in HPV infection. The two previous
studies that analyzed global gene expression changes in early-stage HPV infection may
not have observed changes in the expression of LCE genes since they used monolayer
cultures, which do not allow the formation of the four strata of differentiating kerati-
nocytes in the epidermis (22, 23). The three laminin genes LAMA3, LAMB3, and LAMC2
encode the three subunits that make up laminin 5, which plays an important role in
wound healing, keratinocyte adhesion, motility, and proliferation (53, 54).
Genes from 16 GO terms were included in the protein association analysis for
inflammation (Fig. 3D; Table S9). The gene for ubiquitin C (UBC), which is downregu-
lated 2.48-fold with HPV16 infection, is at the center of this network and has the most
associations with other genes related to inflammation. UBC is one of the two polyu-
biquitin genes that are involved in various cellular processes, including protein degra-
dation, protein trafficking, cell cycle regulation, DNA repair, and apoptosis (55). Other
ubiquitin-related genes that were significantly downregulated in our microarray anal-
ysis included those for proteins that are involved in ubiquitin conjugation (UBE2G1,
UBE2F, UBR4, UBTD1), whereas two of the four ubiquitin-related genes that were
significantly upregulated are involved in deubiquitination (USP1, USP13). This suggests
that a decrease in ubiquitination may be important in the HPV16 life cycle and that the
virus is trying to achieve this by decreasing ubiquitination and increasing deubiquiti-
nation. In previous studies, UBR4 has been shown to be a cellular target of the HPV16
E7 oncoprotein (56, 57), and we have shown that HPV16 upregulates the deubiquiti-
nase UCHL1 in order to escape host immunity (58). Since ubiquitins are involved in
many cellular processes, it is hard to identify which specific pathway is affected by the
decrease in ubiquitination. It is possible that the virus prevents the degradation of
proteins that are targeted by ubiquitin. Also, since our results suggest that HPV
infection drives the cell cycle and downregulates cell death, it is possible that the
downregulation of ubiquitination is involved in these processes. The network also
included cytokines (IL1A, IL1B, IL36B), mitogen-activated protein kinases (MAPK13,
MAP2K4, MAP3K9), proteases (CTSD, CTSC, KLK7, FURIN), serine protease inhibitors
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(SERPINB1, SERPINE1), and antimicrobial genes (S100A7, RNASE7, PRSS3, HIST1H2BC,
HIST1H2BE, HIST1H2BG, LCN2). Among these genes, MAP3K9, CTSD, CTSC, SERPINE1,
HIST1H2BC, HIST1H2BE, and HIST1H2BG have not yet been reported to be associated
with HPV infection by previous gene expression studies. Of note, RNASE7 is a broad-
spectrum antimicrobial protein that we have previously shown is downregulated by
HPV infection (59). In terms of specific signaling pathways, the regulation of IB kinase
(IKK) and NF-B signaling was significantly represented in the network (Fig. 3D,
highlighted in red), which is consistent with our previous study that showed suppres-
sion of NF-B activation by HPV16 (60). Most of these genes were shown to interact
with UBC (Fig. 3D), and it is known that ubiquitination and proteolytic degradation of
NF-B inhibitor IB can lead to NF-B activation (61). This suggests that HPV16 evades
the immune system by suppressing the NF-B pathway and that this suppression may
be mediated by downregulation of UBC.
Lastly, genes from 4 GO terms were included in the protein association analysis for
cell death and gave 5 small networks (Fig. 3E; Table S10). The networks included genes
from the JNK signaling pathway (TIAM1, IL1B, VANGL2, CTGF, WNT7B), suggesting that
HPV16 may suppress cell death and promote transformation and tumorigenesis
through this pathway. This is consistent with our previous study that showed the
downregulation of cell death with HPV infection (62). Both the NF-B and JNK pathways
are downstream of tumor necrosis factor (TNF) signaling, and TNF ligands and receptors
(TNFRSF19, LITAF, TNFSF9) were downregulated in the microarray. This suggests that
HPV16 downregulates NF-B and JNK pathways via TNF signaling downregulation.
Among these genes, TIAM1, VANGL2, WNT7B, TNFRSF19, and LITAF have not yet been
reported to be associated with HPV infection by previous gene expression studies.
Gene transcription changes correlate with changes in protein expression. Of
the numerous biological processes that were identified with GO analysis, we wanted to
focus on processes and pathways that we felt were unique and most relevant to HPV
infection and the life cycle. Therefore, four genes that are involved in processes
involving epidermal development and differentiation (KLK8, RPTN, KRT23) and the
immune response (SERPINB4) and that were modulated at least 10-fold were selected
for validation. Additionally, UBC was selected for validation since it was shown to be
central to the protein association network of inflammation (Fig. 3D), and cyclin-
dependent kinase 2 (CDK2) was included for analysis as a marker of proliferation. In our
microarray analysis, KLK8, RPTN, KRT23, SERPINB4, and UBC were downregulated 25.8-,
57.5-, 11.1-, 48-, and 2.48-fold, respectively, and CDK2 was upregulated 1.74-fold with
HPV16 infection. KRT23 is a structural protein in epithelial cells, whereas KLK8 and RPTN
are involved in the skin barrier proteolytic cascade and cornified cell envelope forma-
tion, respectively (63, 64). Recently, studies have reported that KRT23 may be involved
in other cellular processes, including cell cycle regulation and apoptosis (65), which are
key processes that were modulated by HPV infection in our study. KRT23 has not yet
been reported by any other gene expression studies of HPV infection and, therefore,
could be developed into a novel biomarker of productive HPV infection. In a recent
gene expression profiling study, SERPINB4 was shown to be downregulated in early-
stage HPV infection, consistent with the findings of our analysis (23). SERPINB4 is a
serine protease inhibitor that is overexpressed in inflammatory skin diseases and
various cancers, including squamous cell carcinomas, and may play a critical role in the
immune response against HPV replication and virion production, as it has been shown
that increased SERPINB4 expression can activate NF-B (66–72). Similarly, KLK8 has
been shown to be overexpressed in cervical cancer, ovarian cancer, and oral squamous
cell carcinoma (73–76). So far, not much is known about these proteins in the context
of preneoplastic HPV infections, and therefore, they could potentially become biomark-
ers or therapeutic targets of HPV infection at its early stages. In particular, overexpres-
sion of SERPINB4 and KLK8 in cancers prominently contrasts our microarray data, which
include the two genes among the top downregulated genes. This contrast highlights
the different microenvironments of the precancerous and cancerous states of HPV
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infection, and understanding the role of SERPINB4 and KLK8 may provide critical insight
into the mechanism of HPV-induced carcinogenesis.
In order to increase the rigor of our data, all of the raft cultures for the validation
experiments were set up with new cell lines, except for one set of 16HCK rafts. The
downregulation of KLK8, RPTN, and SERPINB4 and the upregulation of CDK2 at the
transcriptional level were observed with HPV16 infection at both 10 days and 20 days
of culture, consistent with the results of microarray analysis (Fig. 4). Transcription of UBC
was significantly decreased with HPV16 infection at 10 days of culture, as expected
from our microarray analysis (Fig. 4A), but was slightly increased at 20 days of culture
(Fig. 4B). We then further validated the downregulation of KLK8, RPTN, KRT23, and
SERPINB4 at the translational level by Western blotting at 10 days (Fig. 5A and B) and
20 days (Fig. 5C and D) of culture. Although KLK8 expression was visibly downregulated
with HPV16 infection by Western blotting, statistical significance was not reached on
either 10 days or 20 days of culture. To measure UBC protein expression, we used an
antiubiquitin antibody as a proxy for measuring UBC translation since UBC is simply a
polyubiquitin protein that accounts for the majority of basal-level ubiquitin in cells (55,
77). Western blotting against ubiquitin showed the differential ubiquitination of various
proteins with HPV16 infection (Fig. 5E and F) and the downregulation of monoubiquitin
at 20 days of culture (Fig. 5F). Lastly, the downregulation of RPTN, KRT23, SERPINB4, and
ubiquitin was validated with immunofluorescence staining (Fig. 6). In particular, RPTN,
KRT23, and SERPINB4 were minimally expressed in the basal layers of both infected and
uninfected controls, with no significant difference in expression between the two
groups. In contrast, the three proteins were strongly expressed in the upper layers of
uninfected tissues, and this expression was significantly decreased with HPV16 infec-
tion. The downregulation of the proteins may be attributed to the loss of the cornified
layer in infected raft tissues.
DISCUSSION
In an attempt to understand HPV infection and its progression to cancer at a holistic
level, many studies have investigated the global gene expression changes that occur
with HPV infection. Most of these studies focus on neoplastic and cancerous lesions
(13–21). Two previous studies used early-passage HPV16 cell lines, but only 28.1% and
1.6% of the genes reported to be modulated matched our results, and moreover, some
of the genes were modulated in the opposite direction (22, 23). The discrepancies
between our study and the two previous studies can be attributed to our use of an
organotypic raft culture system and cervical cells instead of monolayer cell cultures and
foreskin cells. Since the HPV life cycle spans all layers of the epidermis, monolayer cell
FIG 4 RT-PCR of genes of interest. RNA was extracted from day 10 (A) and day 20 (B) raft tissues, and
RT-PCR was performed to measure the transcription levels of SERPINB4, KLK8, RPTN, CDK2, and UBC. For
experiments with day 10 raft tissues (A), three raft experiments, each with 16HCK and primary HCK cell
lines representing three donors each, were set up. For experiments with day 20 raft tissues (B), six raft
experiments, each with 16HCK and primary HCK cell lines representing three and six donors, respectively,
were set up. The transcription level of the TATA-binding protein (TBP) was used as a control to normalize
each measurement (statistical significance, P  0.05, two-tailed t test). The variance of relative expression
ranged from 0.0001 to 0.65 for day 10 raft tissue and from 0.0012 to 2.96 for day 20 raft tissue.
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cultures cannot produce progeny virus particles and, therefore, are limited models of
HPV infection. Viral titers were measured on all 16HCK raft tissues to check for high
levels of viral particle production (Table 1) and confirmed productive infection. Inte-
gration of the viral genome into the host genome and the subsequent reduction in viral
particle production are hallmark events in the progression of precancerous to cancer-
ous lesions, and thus, high levels of viral particle production indicate that the infection
is in its earlier precancerous stages. Our study presents for the first time the global gene
expression changes in cervical tissue with productive HPV infection.
Our microarray data showed that the majority of the modulated genes are down-
regulated (Fig. 1). Gene ontology analysis of the microarray data identified gene
categories that were significantly represented, including cell cycle progression and DNA
metabolism for the upregulated genes and skin development, immune response, and
FIG 5 Western blot analysis of raft tissue. (A and C) Expression of the SERPINB4, KLK8, RPTN, and KRT23 protein was tested by Western blotting
of primary HCK and 16HCK raft tissue harvested at day 10 (A) and day 20 (C). (B and D) Densitometry analysis was conducted on the Western
blots at day 10 (B) and day 20 (D) (statistical significance, P  0.05, two-tailed t test). The variance of relative expression ranged from 0.00037 to
0.27 for day 10 raft tissue and from 0.00029 to 0.86 for day 20 raft tissue. (E and F) Protein expression of ubiquitin was tested by Western blotting
of primary HCK and 16HCK raft tissue harvested at 10 days (E) and 20 days (F) of culture. For experiments with day 10 raft tissues (A, B, E), three
raft experiments, each with 16HCK and primary HCK cell lines representing three donors each, were set up. For experiments with day 20 raft
tissues (C, D, F), six raft experiments, each with 16HCK and primary HCK cell lines representing three and six donors, respectively, were set up.
GAPDH was used as a control. Images were acquired with a Bio-Rad ChemiDoc MP imaging system and Image Lab (v6.0.0) software.
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cell death for the downregulated genes (Fig. 2). The upregulation of cell cycle and DNA
metabolism genes and the downregulation of cell death genes reflect the proliferative
nature of persistent HPV16 infection. The downregulation of immune response and skin
development genes can be understood in the context of the virus modulating the host
environment to achieve efficient replication and virion production. The trends of
modulation in these five gene categories are consistent with previously reported
studies of global gene expression (13, 15–19, 22, 23, 27, 28, 34, 38, 39).
Several genes were selected for validation at the transcription and translational
levels based on the degree of the fold change in expression, relevance to the HPV life
cycle, and protein association network analysis. KLK8 and RPTN were selected for
validation as they were among the top downregulated genes and are both involved in
epithelium development. It is not surprising to see many genes involved in epithelium
development to be affected by HPV infection since the virus infects, replicates, and
assembles in the epithelium. In particular, HPV is not a lytic virus and is released from
FIG 6 Immunofluorescence staining of raft tissue. The spatial protein expression of SERPINB4, RPTN, KRT23, and ubiquitin was observed by
performing immunofluorescence staining of primary HCK and 16HCK raft tissue fixed at 10 days and 20 days of culture (green, target protein; blue,
nuclear staining). For experiments with day 10 raft tissues, three raft experiments, each with 16HCK and primary HCK cell lines representing three
donors each, were set up. For experiments with day 20 raft tissues, six raft experiments, each with 16HCK and primary HCK cell lines representing
three and six donors, respectively, were set up. Magnifications, 200. H&E, hematoxylin and eosin staining. Images were acquired with a Nikon
Eclipse 80i microscope and NIS Elements (version 4.4) software.
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the epidermis via desquamation. Repetin was downregulated 57.5-fold with HPV16
infection in our microarray analysis, and this downregulation was validated by quan-
titative PCR (qPCR), Western blotting, and immunofluorescence (IF) staining. Repetin is
a component of the epidermal differentiation complex and is involved in the formation
of the cornified cell envelope (CE) (64). The CE is an insoluble matrix of covalently linked
proteins formed beneath the plasma membrane of differentiating keratinocytes and
plays an important role in the skin’s function as a protective physical barrier against the
external environment (78). In the context of HPV infection, the CE may hinder virion
release because of its function as a physical barrier. Additionally, a previous study has
shown that CEs of epithelial tissue infected with HPV11 are thinner and more fragile
than those of healthy tissue (79). Therefore, it can be speculated that the downregu-
lation of repetin by HPV may be a strategy to weaken the CE and increase the efficiency
of virion release.
KLK8 was downregulated 25.8-fold in our microarray analysis, which was validated
with qPCR and Western blotting. KLK8 was the most significantly downregulated gene
of the seven kallikrein-related peptidase (KLK) genes that were downregulated with
HPV16 infection; KLK3, KLK5, KLK6, KLK7, KLK10, and KLK13 were downregulated 3.6-, 4-,
22.1-, 8.6-, 7.5-, and 21.5-fold, respectively. A previous gene expression study also
identified a cluster of KLK genes (KLK5, KLK6, KLK7, KLK10, KLK11) that are downregu-
lated at early stages of HPV16 infection (22). KLKs are a family of 15 serine proteases
that are clustered on chromosome 19q13.4, and one of their main functions is cleaving
corneodesmosomal adhesion molecules in the cornified layer of the epidermis, which
allows regulated desquamation of keratinocytes (63, 80–82). It is counterintuitive that
HPV16 infection downregulates KLKs, since the virus is released via desquamation. We
speculate that the rate at which normal epithelium desquamates is higher than the rate
at which HPV virions mature in the cornified layer, and therefore, the virus may
downregulate KLKs in order to impede desquamation and allow virions to adequately
mature before being released to the surrounding environment. KLK8 also plays a role
in activation of the antimicrobial peptide LL-37, and thus, HPV16 may downregulate the
protein in order to prevent antimicrobial reaction (63, 83).
SERPINB4, also known as squamous cell carcinoma antigen 2 (SCCA2), is a member
of the serpin family of serine protease inhibitors and was downregulated 48-fold in our
microarray analysis. The downregulation in microarray analysis was validated with
qPCR, Western blotting, and IF staining. SERPINB4, along with SERPINB3 (squamous cell
carcinoma antigen 1 [SCCA1]), has been shown to be overexpressed in various types of
cancers, including cervical, esophageal, lung, breast, and liver cancers (67, 69–71,
84–86). One of the mechanisms through which SERPINB4 contributes to tumor main-
tenance is the inhibition of granzyme M-induced cell death (87). Additionally, SERPINB4
overexpression is associated with inflammatory diseases, including psoriasis and atopic
dermatitis (66, 68, 88–90). Remarkably, KLK8 shares the same expression pattern in
these diseases: while our microarray analysis showed significant downregulation during
productive HPV16 infection, the overexpression of KLK8 has also been associated with
both squamous cell carcinomas and inflammatory skin diseases, such as psoriasis and
atopic dermatitis (73–76, 91). We speculate that the virus downregulates SERPINB4 and
KLK8 during productive infection as part of a broad effort to dampen the inflammatory
response. Of particular note is that the two genes are overexpressed in various cancers,
while in our study they are among the top downregulated genes during productive
HPV infection. Additionally, we have identified nine other genes that were significantly
downregulated in our microarray analysis but that have been shown to be overex-
pressed or contribute to disease progression in various types of cancers (Table 4). This
highlights the fact that early productive stages of HPV infection present a microenvi-
ronment and disease state vastly different from those during the cancerous stages of
infection, when virion production is significantly decreased. This suggests that KLK8
and SERPINB4 may interfere with the HPV life cycle or contribute to the immune
surveillance against the virus and, therefore, are downregulated during productive
infection. In contrast, the two proteins may be necessary for tumor maintenance and,
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therefore, are overexpressed during the cancerous stages of infection. However, since
we did not measure the levels of expression of these proteins at cancerous stages, we
cannot definitively compare the protein levels between precancerous and cancerous
stages. A direct comparison would require creating organotypic raft cultures with
cervical cancer cell lines and measuring SERPINB4 and KLK8 protein levels. In future
studies, we aim to investigate the mechanism of KLK8 and SERPINB4 downregulation
and how the two genes affect HPV entry, intracellular trafficking, replication, and
assembly.
UBC was the central protein in the network of proteins encoded by inflammatory
genes that were significantly downregulated with persistent HPV16 infection (Fig. 3D).
qPCR showed a statistically significant downregulation of UBC expression at 10 days of
raft culture (Fig. 4A), while Western blotting of ubiquitin showed the downregulation
of monoubiquitin at 20 days of culture and a differential pattern of protein ubiquiti-
nation (Fig. 5E and F). Additionally, IF staining showed the downregulation of the
protein with persistent infection at both 10 days and 20 days of culture (Fig. 6). Since
ubiquitin is involved in numerous biological processes, it is hard to conclude which
specific pathways are affected by HPV16 infection. However, many proteins that are
associated with UBC in the protein association network (Fig. 3D) are a part of the NF-B
pathway, and we speculate that UBC plays a central role in downregulating this
pathway, especially since it has been shown that the ubiquitin-proteasome pathway
plays a role in NF-B activation. In future studies, we would like to investigate the role
of UBC in relation to the top downregulated genes associated with inflammation, such
as SERPINB4 and KLK8.
In conclusion, our study shows for the first time global gene expression changes
with productive HPV16 infection in an organotypic raft culture model. With gene
ontology analysis, broad gene categories that were significantly modulated with per-
sistent HPV16 infection were identified, and these results were largely consistent with
what previous studies have reported. However, we identified top downregulated genes
that have not yet been extensively studied in the context of HPV infection and that
have the potential to be developed as therapeutic targets or biomarkers. Moreover, the
expression patterns of SERPINB4 and KLK8 highlighted that precancerous and cancerous
stages of HPV infection are two distinct disease states. We attribute these new findings
to our unique model of organotypic raft cultures at early-stage HPV16 infection, which
allows the virus to go through its complete life cycle. Future studies investigating how
the regulation of SERPINB4 and KLK8 changes throughout the different stages of
infection may shed light on unidentified mechanisms of HPV persistence and tumori-
genesis.
MATERIALS AND METHODS
Creating cervical cell lines and organotypic raft cultures. Primary human cervical keratinocytes
(HCK) were isolated from cervical biopsy specimens as previously described (92). The Human Subjects
TABLE 4 Differential gene expression between productive HPV16 infection and cancers
Gene
Fold change in expression
in productive HPV
infection
Cancers in which gene expression increases and/or promotes disease progression
[reference(s)]a
SERPINB4 48.0 HNSCC (67), cervical (69, 71), esophageal (70), lung (99), liver (86), breast (85)
KLK5 3.2 Bladder (100), ovarian (101), lung (102), breast (103), OSCC (75)
KLK6 22.1 Bladder (100), ovarian (101), colorectal (104), HNSCC (105), pancreatic (106)
KLK8 25.8 Bladder (100), ovarian (101), salivary gland (107), cervical (76), OSCC (75), colorectal (106)
KLK10 7.6 Ovarian (101), OSCC (75), pancreatic (106), colorectal (106)
KLK13 21.5 Lung (108), ovarian (109)
MMP9 17.1 Cervical (40), breast (110), HNSCC (111), prostate (112)
MMP10 8.0 OSCC (113), HNSCC (114), esophageal (115)
LCN2 9.1 Breast (42, 43), esophageal (44), pancreatic (45), ovarian (46), colorectal (47), thyroid (48)
CTSD 1.5 Breast (116), ovarian (117)
CTSV 2.8 Breast (118), colorectal (118)
aOSCC, oral squamous cell carcinoma; HNSCC, head and neck squamous cell carcinoma.
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Protection Office of the Institutional Review Board (IRB) at the Penn State University College of Medicine
screened our study design for exempt status according to the policies of this institution and the
provisions of applicable federal regulations and, as submitted, found that it did not to require formal IRB
review because no human participants were involved, as defined by the federal regulations.
HCK cell lines persistently infected with HPV16 (16HCK) were produced by electroporating primary
HCK with HPV16 plasmid DNA as previously described (93, 94). The electroporated cells were cultured
with mitomycin C-treated (Enzo Life Sciences) J2 3T3 feeder cells as previously described (92).
Organotypic raft cultures were grown as previously described (94, 95) at the first or second passage
for primary HCK and the sixth to ninth passage for 16HCK. The raft tissues were harvested after 10 days
for microarray analysis and 20 days for qPCR, Western blotting, and immunofluorescence staining. Viral
gene expression has been shown to peak at between 10 and 12 days (30), while virion maturity reaches
maximum stability at about 20 days (31).
For microarray analysis, three primary HCK cell lines and three 16HCK cell lines— each representing
a different cervical tissue donor—were used to grow raft tissues. These experiments were repeated at
separate time points to represent a total of six individually grown raft tissue specimens (n  6) each for
primary HCK and 16HCK.
For validation experiments (reverse transcription [RT]-qPCR, Western blotting, immunofluorescence
staining), we used primary HCK and 16HCK cell lines from new donors in order to increase the rigor of
our data. Only one 16HCK cell line that was used for the microarray analysis was also used for the
validation experiments, but this raft tissue specimen was grown at a different time point in an
experiment separate from that for tissue grown for the microarray analysis. For experiments with 10-day
rafts, three primary HCK cell lines representing three donors (n  3) and three 16HCK cell lines
representing three different donors (n  3) were used to grow raft tissues. For experiments with 20-day
raft tissues, six raft experiments, each (n  6) with 16HCK and primary HCK cell lines representing three
and six donors, respectively, were set up.
Microarray analysis. Raft tissue from primary HCK and 16HCK were harvested at 10 days, and RNA
was extracted using an RNeasy fibrous tissue midikit (Qiagen). Microarray analysis was performed using
an Illumina HumanHT-12 (v4) expression bead chip (Illumina, San Diego, CA), which targets over 31,000
annotated genes with more than 47,000 probes derived from the National Center for Biotechnology
Information (NCBI) RefSeq Database, release 38 (7 November 2009), and other sources. RNA quality and
concentration were assessed using an Agilent 2100 bioanalyzer with an RNA Nano LabChip (Agilent,
Santa Clara, CA). cRNA was synthesized by TotalPrep amplification (Ambion, Austin, TX) from 500 ng of
RNA according to the manufacturer’s instructions. T7 oligo(dT)-primed reverse transcription was used to
produce first-strand cDNA. The cDNA then underwent second-strand synthesis and RNA degradation by
DNA polymerase and RNase H, followed by filtration clean-up. In vitro transcription (IVT) was employed
to generate multiple copies of biotinylated cRNA. The labeled cRNA was purified using filtration and
quantified by use of a NanoDrop spectrophotometer, and the volume was adjusted for a total of 750
ng/sample. Samples were fragmented and denatured before hybridization for 18 h at 58°C. Following
hybridization, the bead chips were washed and fluorescently labeled. The bead chips were scanned with
a BeadArray reader (Illumina, San Diego, CA).
The CLC Genomics Workbench (v4.8) package (Qiagen Bioinformatics) was used to determine the
genes significantly differentially expressed between the HPV16-positive tissue and primary tissue. For
each comparison, quantile normalization of six primary HCK samples (n  6) and six 16HCK samples
(n  6) was performed, followed by a pairwise homogeneous t test, resulting in normalized fold changes
and P values. Significantly differentially expressed genes were considered to be those with a P value for
differential expression of 0.05 and an absolute fold change in expression of 1.5.
Gene ontology analysis and protein association network. In order to categorize the significant
gene expression changes into Gene Ontology (GO) groups, the GOrilla package was used (http://cbl
-gorilla.cs.technion.ac.il/) (32). Two unranked lists of genes, the target (significantly modulated genes)
and the background (all genes in the microarray), were used to identify significantly enriched GO terms.
We focused on the subontology biological processes for our analysis. The REVIGO web server was used
to further summarize the redundancy in the GO analysis (http://revigo.irb.hr/) (33). In our analysis, we
used a similarity coefficient of 0.7 (medium-size list) to summarize the GO list.
In order to identify protein-protein associations among the upregulated and downregulated genes,
the online tool STRING (https://string-db.org/) was used (50). Genes from similar GO categories were
pooled to form protein association networks of “cell cycle” and “DNA metabolism” for the upregulated
genes, and “skin development,” “immune response,” and “cell death” for the downregulated genes.
Viral titers (DNA encapsidation assay). The viral titers of each raft experiment were measured with
the qPCR-based DNA encapsidation assay described previously (31, 96).
RT-qPCR. RT-qPCR was used in order to measure the levels of transcription of SERPINB4, KLK8, RPTN,
CDK2, and UBC. For SERPINB4, forward primer 5=-ATTTCCTGATGGGACTATTGGCAATG-3=, reverse primer
5=-CAGCAGCACAATCATGCTTAGA-3=, and probe 5=-/FAM/ACGACACTG/ZEN/GTTCTTGTGAACGCA/3IABkF
Q/-3= (where FAM represents 6-carboxyfluorescein and 3IABkFQ represents 3= Iowa Black FQ) were used.
For KLK8, forward primer 5=-TGGGTCCGAATCAGTAGGT-3=, reverse primer 5=-GCAGGAACATCCACGTCTT-
3=, and probe 5=-/FAM/CCCTGGATT/ZEN/CTGGAAGACCTCACC/3IABkFQ/-3= were used. For RPTN, forward
primer 5=-CCACAAATATGCCAAAGGGAATG-3=, reverse primer 5=-GTCATTTGGTCTCTGGAGGATG-3=, and
probe 5=-/FAM/ACTGCTCTT/ZEN/GGCTGAGTTTGGAGA/3IABkFQ/-3= were used. For CDK2, forward primer
5=-GCCTGATTACAAGCCAAGTTTC-3=, reverse primer 5=-CGCTTGTTAGGGTCGTAGTG-3=, and probe 5=-/FA
M/AGATGGACG/ZEN/GAGCTTGTTATCGCA/3IABkFQ/-3= were used. For UBC, forward primer 5=-GGATTT
GGGTCGCAGTTCTT-3=, reverse primer 5=-TGGATCTTTGCCTTGACATTCT-3=, and probe 5=-/FAM/AGGTTGA
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GC/ZEN/CCAGTGACACCATC/3IABkFQ/-3= were used. TATA-binding protein (TBP) was used as a control,
for which forward primer 5=-CACGGCACTGATTTTCAGTTCT-3=, reverse primer 5=-TTCTTGCTGCCAGTCTG
GACT-3=, and probe 5=-HEX-TGTGCACAGGAGCCAAGAGTGAAGA-BHQ-1-3= (where HEX represents
6-carboxy-2,4,4,5,7,7-hexachlorofluorescein and BHQ-1 represents black hole quencher 1) were used. All
primers and probes were synthesized by Integrated DNA Technologies, and a QuantiTect Probe RT-PCR
kit (Qiagen) was used for the PCRs. All RT-PCRs were performed using a C1000 thermal cycler (Bio-Rad).
The thermal cycler was programmed for 30 min at 50°C, then 15 min at 95°C, and then 42 cycles of 15
s at 94°C and 1 min at 54.5°C.
Western blotting. Raft tissues were harvested at 20 days and used to prepare total protein extracts
as previously described (97). Total protein concentrations were measured using the Peterson protein
assay as previously described (98). The total protein extracts were applied to a sodium dodecyl
sulfate-polyacrylamide gel (8 to 10%) and transferred to a nitrocellulose membrane and then incubated
overnight at 4°C with antibodies against SERPINB4 (1:2,000 dilution; catalog number LS-C172681; Life
Span Biosciences), KLK8 (1:2,000 dilution; catalog number H00011202-M01; Abnova), RPTN (1:2,000
dilution; catalog number LS-B17, Life Span Biosciences), KRT23 (1:2,000 dilution; catalog number
ab117590; Abcam), and ubiquitin (1:2,000 dilution; catalog number 3933S; Cell Signaling). GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) antibody (1:1,000 dilution; catalog number sc-47724;
Santa Cruz) was used as a control. The membranes were then washed and incubated with horseradish
peroxidase-linked secondary antibody (catalog number NA931VS/NA934VS; GE Healthcare) and devel-
oped using the Amersham ECL Prime Western blotting detection reagent (GE Healthcare). Densitometry
analysis was conducted by normalizing the protein expression levels to the GAPDH expression level.
Immunohistochemistry and immunofluorescence staining. Raft cultures were fixed in 10% buff-
ered formalin and embedded in paraffin, and 4-m cross sections were prepared. A section from each
sample was stained with hematoxylin and eosin as previously described (26).
For immunofluorescence staining, the slides were submerged in xylene for deparaffinization and
then were rehydrated. Antigen retrieval was achieved by submerging the slides in Tris-EDTA buffer (pH
9) in a 90°C water bath for 10 min. The slides were then rinsed with Tris-buffered saline (TBS)–Tween and
blocked with the Background Sniper blocking reagent (Biocare Medical). The slides were then stained
with the primary antibody overnight at 4°C. Each sample was stained with antibodies against SERPINB4
(1:2,000 dilution; catalog number LS-C172681; Life Span Biosciences), RPTN (1:1,000 dilution; catalog
number LS-B17; Life Span Biosciences), KRT23 (1:500 dilution; catalog number ab117590; Abcam), and
ubiquitin (1:750 dilution; catalog number 3933S; Cell Signaling). The slides were then rinsed with
TBS-Tween 3 times and stained with secondary antibody (Alexa Fluor 488; Life Technologies) diluted
1:200 for 1 h at room temperature. Next, the slides were stained with Hoechst nuclear stain (1:5,000
dilution) for 15 min and rinsed with TBS-Tween twice. All antibodies were diluted in Da Vinci Green
diluent (Biocare Medical). The experiment was conducted with three primary HCK and three 16HCK
samples in duplicate. A Nikon Eclipse 80i microscope and NIS Elements (v4.4) software were used to
acquire images.
Statistical analysis. The microarray data shown in Fig. 1 are quantile-normalized means for six
primary HCK and six 16HCK samples determined using the CLC Genomics Workbench (v4.8) software
package. Statistical significance was determined with the homogeneous t test, using the CLC Genomics
Workbench (v4.8) software package.
In order to establish statistical significance in qPCR data and Western blotting densitometry analysis,
a t test with a P value cutoff of 0.05 was used.
Accession number(s). The GEO accession number for our microarray data is GSE109039.
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